Metodopramide 10 mg given intramuscularly twice daily for two days from the end of uncomplicated cholecystectomies has been compared with placebo in a double-blind trial on sixty women. Nausea, retching and vomiting were recorded for 6 hours, and retching and vomiting for another 12 hours postoperatively. Intestinal peristalsis was evaluated by auscultation for bowel sounds and questioning the patients for passage of flatus from the evening of the day of operation till the second postoperative day. The metoclopramide-treated group had less nausea, retching and vomiting than the placebo group, the difference being close to statistical significance (P=0.08). A statistically significant shortening of the postoperative period of intestinal paralysis was found (P<0.05).
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In a previous study, we have shown that intramuscular injection of metodopramide 10 mg at the end of gynaecological laparotomies gave better protection against nausea and vomiting than did perphenazine 5 mg (Lind and Breivik, 1970) . However, in upper abdominal operations, Dobkin, Evers and Israel (1968) could not demonstrate a significant anti-emetic effect with either metodopramide 20 mg or trimethobenzamide 300 mg given intravenously at the end of the operation compared with placebo. They concluded that only gastric suction protected their patients against nausea and vomiting. This discrepancy encouraged us to investigate the anti-emetic property of metodopramide in patients after upper abdominal laparotomies where gastric suction was not instituted.
Metodopramide has a stimulating effect on propulsive peristalsis of the upper gastrointestinal tract (James and Hume, 1968; Connell and George, 1969) . Psathakis (1967) administered metodopramide 10 mg twice daily after major laparotomies and conduded that metodopramide prevented postoperative intestinal paralysis. He did not, however, have a control group of placebotreated patients. Banke (1969) study in which metodopramide 10-15 mg or placebo was given thrice daily to patients after operation for peptic ulcer to hasten recovery of normal intestinal function. The second purpose of this investigation was to see if these results could be confirmed in a double-blind study.
MATERIALS AND METHODS
Sixty female patients, 20-69 years of age, who underwent uncomplicated cholecystectomies, were given either metoclopramide 10 mg or saline intramuscularly from identical, coded ampoules at the end of the operation, at 8 p.m. on the same day, and at 7 a.m. and 2 p.m. on the first postoperative day. Thus, altogether four injections of either metoclopramide 10 mg or saline were given. Table I shows the distribution of the material. Premedication consisted of pethidine 75 mg and atropine 0.6 mg. Anaesthesia was induced with thiopentone, an endotracheal tube was passed under suxamethonium apnoea, and anaesthesia was maintained with halothane 0.5 per cent in a 30/70 oxygen/nitrous oxide mixture. Alcuronium was given for muscle relaxation, and pulmonary ventilation was controlled. The only postoperative analgesic given was pethidine 50-75 mg.
Nausea, retching and vomiting were recorded in the recovery room for the first 6 hours postoperatively, and the patients were given nausea scores (land and Breivik, 1970) . For the next 12 hours only retching and vomiting were recorded.
Intestinal peristalsis was identified by auscultation of the abdomen for bowel sounds for 5-minute periods, and by questioning the patients for passage of flatus. These observations were recorded at 8 pjn. on the day of operation, at 8 a.m. and 8 p.m. on the first postoperative day and at 8 a.m. on the second postoperative day.
The patients were given a score for intestinal peristalsis as illustrated in table II. We consider that the passage of flatus is a more reliable sign of propulsive intestinal function than is the presence of bowel sounds. Therefore, the passage of flatus has been given the higher score. Furthermore, the shorter the time after the operation at which these signs appeared, the higher the score given for both. Student's f-test was used to determine the statistical significance of the differences between the scores for nausea and propulsive peristalsis of the two groups. A -//-test was used to determine the significance of differences in incidence of retching and vomiting between the two groups. Two-sided significance tests were used.
RESULTS

Anti-emetic effect.
The incidence of retching and vomiting during the first 6 hours postoperatively was higher in the placebo group (table III) . The difference is close to statistical significance x*=3-224, P=0.08. The nausea-score in the placebo group was also higher than in the metoclopramide group (table HI), but the difference was not significant (P=0.11). The incidence of retching and vomiting during the next 12 hours was higher in the placebo group (table  IV) , although it did not quite achieve statistical significance (y a = 2.87, P=0.09). Data from four patients omitted because gastric suction was decided upon, in two patients because of intolerance for pethidine, another analgesic being given.
Intestinal peristalsis.
Passing of flatus and bowel sounds appeared earlier in the metoclopramide group than in the placebo group ( fig. 1) . Bowel sounds were heard in 50 per cent of the patients in the metoclopramide group in the evening of the day of the operation compared with 33 per cent in the placebo group. In the morning of the second postoperative day, 52 per cent of the patients in the metoclopramide group had passed flatus whereas this was the case in 26 per cent of the patients in the placebo group. Both of these recorded observations were combined in the score for intestinal peristalsis, which was higher in the metoclopramide group (11.93 +1.26, mean ± SE) than in the placebo group (8.60 ±0.99, mean±SE), the difference being statistically significant (t {8 = 2.070; 0.04<P<0.05).
The number of pethidine injections in the first 24 hours postoperatively was the same in both groups, 2.5 injections per patient in the metoclopramide group, and 2.8 injections per patient in the placebo group (table I) .
DISCUSSION
In this study of female patients following cholecystectomy, the patients in the metoclopramide group suffered less nausea, retching and vomiting than the patients in the placebo group. The difference is, however, not of definite statistical significance. The discrepancy between our previous study on gynaecological laparotomies (Lind and Breivik, 1970 ) and the observations of Dobkin, Evers and Israel (1968) on upper abdominal operations may be explained by the different kind of operation. The conclusion of Dobkin, Evers and Israel (1968) that gastric suction is the only effective prophylactic measure against nausea and vomiting after upper abdominal operations was thus not conclusively disproved by our present study; but our results do indicate that a certain anti-emetic effect of metoclopramide in females after cholecystectomies is very probable; a larger number of patients would have given a more definite answer to this question.
Auscultation for bowel sounds and questioning the patients about the passage of flatus are crude methods of recording initiation of intestinal function postoperatively. Still, a small but significant shortening of the postoperative intestinal paralysis was found in favour of metoclopramide. The importance of such an effect in uncomplicated postcholecystectomy patients may not be great, but if verified by more accurate methods of recording intestinal peristalsis, metoclopramide may prove to be a valuable adjunctive measure after operations associated with pronounced intestinal paralysis. 
PROPRIETIES ANTIEMETIQUES ET
PROPIEDADES ANTIEMETICAS Y PERISTALTICAS PROPULSIVAS DE LA METOCLOPRAMIDA
RESUMEN
La metoclopramida 10 mg administrada por via intramuscular dos veces al dia durante dos dias desde el final de colecistectomias no complicadas ha sido comparada con placebo en una prueba doble ciego en sesenta mujeres. Fueron registrados nauseas, bascas y vomitos durante 6 horas y bascas y vomitos durante otras 12 horas postoperatoriamente. El peristaltimo intestinal fue evaluado mediante auscultaci6n para ruidos intestinales y preguntando a los pacientes sobre el paso de flatos desde la tarde del dia de la operaci6n hasta el segundo dia postoperatorio. El grupo tratado con metoclopramida tenla menos nausea, bascas y vomitos que el grupo placebo, siendo la diferencia cercana a una significaci6n estadfstica (P=0,08). Fue observado un acortamiento estadisticamente signifkativo del periodo postoperatorio de par&lisis intestinal (P<0,05).
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